Advanced search
Publication Cover
Leukemia & Lymphoma Volume 53, 2012 - Issue 4
Submit an article Journal homepage
288
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Double high-dose therapy with dose-intensive cyclophosphamide, etoposide, cisplatin (DICEP) followed by high-dose melphalan and autologous stem cell transplantation for relapsed/refractory Hodgkin lymphoma

Mona ShafeyDepartments of Oncology and Medicine, Tom Baker Cancer Centre and University of CalgaryCorrespondence[email protected]
,
Qiuli DuanBiostatistics, Clinical Research Unit, Tom Baker Cancer Centre
,
James RussellDepartments of Oncology and Medicine, Tom Baker Cancer Centre and University of Calgary
,
Peter DugganDepartments of Oncology and Medicine, Tom Baker Cancer Centre and University of Calgary
,
Alex BaloghOncology, Tom Baker Cancer Centre, Calgary, AB, Canada
&
Douglas A. StewartDepartments of Oncology and Medicine, Tom Baker Cancer Centre and University of Calgary
Pages 596-602 | Received 07 Jul 2011, Accepted 10 Sep 2011, Published online: 27 Apr 2012

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Theodoros Karantanos, Ioannis Politikos & Vassiliki A Boussiotis. (2017) Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin’s lymphoma with an emphasis on targeted therapies and transplantation strategies. Blood and Lymphatic Cancer: Targets and Therapy 7, pages 37-52.
Read now
Gregory MT Guilcher & Douglas A Stewart. (2014) Relapsed Hodgkin lymphoma in adolescents: focus on current high-dose chemotherapy and autologous stem cell transplant. Clinical Oncology in Adolescents and Young Adults 4, pages 1-12.
Read now
Tiziana Moscato, Roberta Fedele, Giuseppe Messina, Giuseppe Irrera, Giuseppe Console & Massimo Martino. (2013) Hematopoietic progenitor cells transplantation for recurrent or refractory Hodgkin's lymphoma. Expert Opinion on Biological Therapy 13:7, pages 1013-1027.
Read now

Articles from other publishers (6)

Al-Anazi Khalid Ahmed, A Alshami, E Mutahar, O Abduljalil, S Kanfer, P Kaloyannidis, J Bacal, A Estanislao, I Apostolidis, N Almokhtar, M Darweesh, M Abdulbaqi, W Alenazi, Z Alshammasi, O Albanyan, A Ayyad, Z Alsomali, M Albatran, H Raslan, A Albahrani, A Alsaber, N AlMulhem, W Dridi, R Alrabeh, F Abu Rahma, F Nightingale, P Ahadai & H Alhashmi. (2023) Outcome of Outpatient Autologous Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma and Relapsed and Refractory Hodgkin Lymphoma. The Experience of King Fahad Specialist Hospital in Dammam, Saudi Arabia. Journal of Stem Cell Therapy and Transplantation 7:1, pages 003-015.
Crossref
Panayotis Kaloyannidis, Rawan Omari, Eman Eldebawy, Eshrak Al Shaibani, John Apostolidis, Taghreed Hindi, Heba Raslan, Ayed Al Garni, Ahmed Al Buali, Khalid Al Anezi & Hani Al Hashmi. (2021) Favorable Outcome After Adjuvant Involved-Field Radiotherapy After Autologous Hematopoietic Stem-Cell Transplantation in Patients With High-Risk Relapsed/Refractory Lymphoma: A Single-Center Experience. Clinical Lymphoma Myeloma and Leukemia 21:2, pages e112-e119.
Crossref
Hani Alhashmi, Magdy Kandil, Ayman Alhejazi, Ibraheem Motabi, Ahmed Sagheir, Musa Alzahrani, Reyad Dada & Mubarak Al-Mansour. (2019) Hodgkin's lymphoma: Saudi Lymphoma Group's clinical practice guidelines for diagnosis, management and follow-up. Saudi Journal of Medicine and Medical Sciences 7:3, pages 195.
Crossref
. 2017. Hematopoietic Cell Transplants. Hematopoietic Cell Transplants 361 444 .
Mark Hertzberg. (2014) Relapsed/Refractory Hodgkin Lymphoma. Hematology/Oncology Clinics of North America 28:1, pages 123-147.
Crossref
. (2013) Current World Literature. Current Opinion in Organ Transplantation 18:1, pages 111-130.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.